Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing molecular mechanisms without systematic review methods or new clinical data
PubMed 38902597 · doi:10.1186/s10020-024-00842-7
What was done
The authors conducted a narrative review of recent literature examining the molecular mechanisms through which sulforaphane (SFN)—an isothiocyanate derived from glucosinolates—acts in cancer prevention and therapy.
What was found
The abstract reports no numerical data or quantitative outcomes. Qualitatively, it highlights that sulforaphane upregulates phase II detoxification enzymes via the Nrf2 pathway to counter oxidative stress, activates apoptotic pathways in cancer cells, impedes cell cycle progression, and suppresses cancer stem cells.
Why it matters
It provides a consolidated summary of the diverse biological pathways targeted by sulforaphane, highlighting its potential utility as a multi-target adjuvant or preventative agent in oncology.
Limits
The paper is a non-systematic narrative review providing no quantitative synthesis, risk-of-bias assessment, or human clinical trial efficacy data, relying almost entirely on preclinical mechanistic models.
Cited by
- supports Sulforaphane activates the Nrf2 transcription factor pathway, which upregulates Phase 2 detoxification enzymes that convert toxins into water-soluble forms.